Lv6
1670 积分 2024-12-24 加入
Process Development for a TLR-7 Immunostimulatory Drug-Linker: Salt Screening and Precipitation for Drug-Linker Intermediates
4天前
已完结
LC–MS/MS Strategies for Therapeutic Antibodies and Investigation Into The Quantitative Impact of Antidrug-Antibodies
5天前
已关闭
LC–MS/MS Strategies for Therapeutic Antibodies and Investigation Into The Quantitative Impact of Antidrug-Antibodies
5天前
已关闭
Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper
5天前
已完结
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
5天前
已完结
Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma
5天前
已完结
Accurate determination of drug-to-antibody ratio of interchain cysteine-linked antibody–drug conjugates by LC-HRMS
5天前
已完结
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors
5天前
已关闭
The potential of targeting Wnt/β-catenin in colon cancer
5天前
已完结
In-depth Characterization of Photo-Stressed Antibody–Drug Conjugates by Mass Spectrometry
7天前
已完结
皖公网安备34019202002308
